Access to COVID treatments for highest-risk patients
From 27 June, integrated care boards (ICBs) will have statutory responsibility for providing access to community based COVID treatments. Highest-risk patients who can be digitally identified will receive a letter saying they will no longer be contacted if they test positive, but instead should contact local services. To ensure patients access treatment promptly, ICBs should work with primary care and other providers, to develop local clinical pathways for oral antivirals and IV treatments.